Presentation is loading. Please wait.

Presentation is loading. Please wait.

Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA.

Published bySivert Aas Modified over 5 years ago

Similar presentations

Presentation on theme: "Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA."— Presentation transcript:

1 Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non–small cell lung cancer: A prospective study  Jun-ichi Yamashita, MDa*, Akinobu Matsuo, MDa*, Yuji Kurusu, MDa, Tetsushi Saishoji, MDb, Naoko Hayashi, MDa, Michio Ogawa, MDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 124, Issue 2, Pages (August 2002) DOI: /mtc Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Overall survival in 103 patients with NSCLC who underwent a curative lobectomy in terms of pTNM stage of disease. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Overall survival in 103 patients with NSCLC who underwent a curative lobectomy in terms of preoperative and postoperative CEA mRNA status. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Overall survival in 103 patients with NSCLC who underwent a curative lobectomy in terms of CEA mRNA expression pattern. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Overall survival in 103 patients with NSCLC who underwent a curative lobectomy in terms of CEA mRNA expression pattern according to the pTNM stage. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

6 Fig. 5 Overall survival in 103 patients with NSCLC who underwent a curative lobectomy in terms of the sequence of pulmonary vessel ligation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA."

Similar presentations

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.

A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.

Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Sleeve lung resection for lung cancer: Analysis according to the type of procedure  Kazumichi Yamamoto, MD, Yoshihiro Miyamoto, MD, Akihiro Ohsumi, MD,

Sleeve lung resection for lung cancer: Analysis according to the type of procedure  Kazumichi Yamamoto, MD, Yoshihiro Miyamoto, MD, Akihiro Ohsumi, MD,
Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,
John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,

Similar presentations

Ads by Google